Back
Cullinan Therapeutics, Inc. 10K Form
Sell
42
CGEM
Cullinan Therapeutics, Inc.
Last Price:
$14.45
Seasonality Move:
-4.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CGEM News And Ratings
See the #1 stock for the next 7 days that we like better than CGEM
CGEM Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-38.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.78 |
| Price / Book: | 2.21 |
Profitability
| EPS (TTM): | -3.72380 |
|---|---|
| Net Income (TTM): | $-219.9M |
| Gross Margin: | $-311K |
| Return on Equity: | -44.07% |
| Return on Assets: | -41.4% |
Cullinan Therapeutics, Inc. Earnings Forecast
Key Cullinan Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 10 years have been positive in 2 years.
Cullinan Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CGEM |
| Website: | cullinantherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 10.25 |
| Quick Ratio: | 10.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CGEM Technical Analysis vs Fundamental Analysis
Sell
42
Cullinan Therapeutics, Inc. (CGEM)
is a Sell
Is Cullinan Therapeutics, Inc. a Buy or a Sell?
-
Cullinan Therapeutics, Inc. stock is rated a SellThe current Cullinan Therapeutics, Inc. [CGEM] share price is $14.43. The Score for CGEM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.